Natalie C. Edwards

Comparing the Cost-Effectiveness of Disease-Modifying Drugs for the First-Line Treatment of Relapsing-Remitting Multiple Sclerosis

Lawrence Goldberg, Natalie C. Edwards, Contessa Fincher et al. · Journal of Managed Care Pharmacy · 2009 · 106 citations · Full text

Pharmacy, Neurology, Pharmacoeconomics +10

Cost effectiveness of long-acting risperidone injection versus alternative antipsychotic agents in patients with schizophrenia in the USA

Natalie C. Edwards, Julie Locklear, Marcia F.T. Rupnow et al. · PharmacoEconomics · 2005 · 67 citations

Pharmacy, Pharmacoeconomics, Psychiatry +16

Comorbidity in US patients with multiple sclerosis

Natalie C. Edwards, Michael Munsell, Joseph Menzin et al. · Patient Related Outcome Measures · 2018 · 55 citations · Full text

Education, Neurology, Clinical Epidemiology +13

Cost-Effectiveness Model Of Long-Acting Risperidone in Schizophrenia in the US

Natalie C. Edwards, Marcia F.T. Rupnow, Chris L. Pashos et al. · PharmacoEconomics · 2005 · 42 citations

Pharmacy, Pharmacoeconomics, Psychiatry +14

Background to Understanding Value-Based Surgical Spine Care

Matthew J. McGirt, Daniel K. Resnick, Natalie C. Edwards et al. · Spine · 2014 · 23 citations

Public Affairs, Health Policy, Surgery +17